Manufacturer
Padagis US LLC
30 drugs, 45 product strengths, 8 recalls on record.
Drugs Padagis US LLC makes
Methylphenidate-1.0%Generic · 28 makersPharmacies pay from$3.65Unavailable1 open recallAspirin+0.2%Generic · 162 makersPharmacies pay from$0.43Being discontinued2 open recallsSpironolactone-0.1%Generic · 35 makersPharmacies pay from$1.28Being discontinued3 open recallsParoxetine+2.3%Generic · 38 makersPharmacies pay from$1.886 open recallsBudesonide+4.1%Generic · 33 makersPharmacies pay from$15.543 open recallsTretinoin+0.9%Generic · 26 makersPharmacies pay from$9.273 open recallsTestosterone-3.4%Generic · 29 makersPharmacies pay from$35.2068 open recallsTofacitinib-4.8%Generic · 22 makersPharmacies pay from$16.86Clotrimazole+0.4%Generic · 113 makersPharmacies pay from$3.556 open recallsBisacodyl-5.8%Generic · 73 makersPharmacies pay from$1.251 open recallVitamin K1+5.4%Generic · 32 makersPharmacies pay from$279MidazolamNo changeGeneric · 19 makersPharmacies pay from$11.32Unavailable3 open recallsTrospium-2.2%Generic · 20 makersPharmacies pay from$6.201 open recallHydromorphone+0.5%Generic · 15 makersPharmacies pay from$5.12Unavailable3 open recallsCiclopirox-0.1%Generic · 13 makersPharmacies pay from$2.533 open recallsBrompheniramine / dextromethorphan / pseudoephedrine+0.4%Generic · 14 makersPharmacies pay from$8.08Dexamethasone / tobramycin+2.6%Generic · 12 makersPharmacies pay from$21.44Acetylcysteine+4.2%Generic · 13 makersPharmacies pay from$96.564 open recallsLidocaine / prilocaine-3.7%Generic · 13 makersPharmacies pay from$6.70Loteprednol etabonate-0.4%Generic · 9 makersPharmacies pay from$52.18Bromocriptine+1.1%Generic · 8 makersPharmacies pay from$48.811 open recallBenazepril / hydrochlorothiazide+1.7%Generic · 6 makersPharmacies pay from$6.38Methazolamide+1.7%Generic · 6 makersPharmacies pay from$19.15Brinzolamide-6.8%Generic · 5 makersPharmacies pay from$79.50Amiloride+3.4%Generic · 4 makersPharmacies pay from$5.89Flavoxate-1.9%Generic · 3 makersPharmacies pay from$11.46Podofilox+2.3%Generic · 1 makerPharmacies pay from$53.02Being discontinuedCompro+0.4%Brand · prochlorperazinePharmacies pay from$81.25Evamist+0.1%Brand · estradiolNo weekly price1 open recallNystop-2.5%Brand · nystatinPharmacies pay from$4.58
Recalls
Class IIOngoingJul 22, 2026Nystatin Cream USPSubpotent Drug: Low out of specification assay results performed during long-term stability testing.Padagis US LLC · D-0677-2026Class IICompletedMar 5, 2025Estradiol GelDefective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.Padagis US LLC · D-0246-2025Class IIITerminatedNov 27, 2024Triamcinolone Acetonide Cream USPSubpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.Padagis US LLC · D-0048-2025Class IIOngoingDec 13, 2023Trospium Chloride Extended-Release CapsulesFailed Tablets/Capsules specifications; missing/broken/extra tablets within the capsulesPadagis US LLC · D-0139-2024Class IIOngoingNov 8, 2023Gynazole-1Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing...Padagis US LLC · D-0081-2024Class IIIOngoingMar 22, 2023EvamistFailed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability...Padagis US LLC · D-0464-2023Class IITerminatedSep 7, 2022Triamcinolone Acetonide Cream USPCGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.Padagis US LLC · D-1497-2022Class IITerminatedJan 19, 2022Nitroglycerin Lingual SprayDefective Delivery SystemPadagis US LLC · D-0372-2022
About Padagis US LLC
No comments yet. Questions, tips, what worked for you - start the conversation.